Table 2.
Subset analysis of lymphocytes from PD patients stratified by gender.
| Group | n | CD3+ T | CD3+CD4+ T | CD3+CD8+ T | CD19+ B | NK |
|---|---|---|---|---|---|---|
| (62%–76%) | (32%–46%) | (18%–32%) | (7%–18%) | (7%–18%) | ||
| PD | 268 | 62.93 ± 9.27 | 33.54 ± 7.59 | 23.68 ± 8.51 | 11.14 ± 4.89 | 22.92 ± 10.08 |
| Control | 268 | 65.75 ± 9.13 | 34.61 ± 7.61 | 24.86 ± 7.87 | 11.93 ± 5.94 | 19.76 ± 10.09 |
| P-value | 0.005 | 0.217 | 0.207 | 0.241 | 0.006 | |
| Male PD | 156 | 62.13 ± 9.66 | 33.07 ± 8.09 | 23.38 ± 9.71 | 10.31 ± 5.21 | 25.16 ± 10.36 |
| Female PD | 112 | 63.96 ± 8.68 | 34.14 ± 6.91 | 24.07 ± 6.65 | 12.14 ± 4.31 | 19.90 ± 8.89 |
| P-value | 0.15 | 0.34 | 0.58 | 0.021 | <0.0001 | |
| Male control | 168 | 64.56 ± 8.24 | 32.97 ± 6.18 | 22.46 ± 7.05 | 11.06 ± 4.58 | 20.78 ± 9.87 |
| P-value (vs Male PD) | 0.03 | 0.46 | 0.61 | 0.09 | 0.008 | |
| Female control | 100 | 66.15 ± 10.44 | 33.67 ± 7.28 | 25.27 ± 8.09 | 12.69 ± 5.97 | 18.42 ± 9.06 |
| P-value (vs Female PD) | 0.001 | 0.25 | 0.36 | 0.32 | 0.09 |
NK, natural killer; PD, Parkinson’s disease; SD, standard deviation. Mean ± SD.